BlackBarn Capital Partners LP 13F: Quarter-over-Quarter Portfolio Changes
BlackBarn Capital Partners LP reported a disclosed portfolio value of approximately $402.2 million in its latest SEC Form 13F-HR filing for Q2 2026, up 21.0% quarter on quarter. Over the quarter, the fund initiated 5 new positions, bought more shares in 3 holdings, trimmed 5 holdings, and exited 2 positions.
BlackBarn Capital Partners LP's top buy was a new stake in Unitedhealth Group INC (UNH) , equal to 6.7% of the disclosed portfolio. Its top sell was Veeco Instrs INC Del (VECO) . The fund exited the position completely after it had accounted for 10.2% of the previous portfolio.
New PositionsQ2 2026
Securities disclosed for the first time in Q2 2026 that were not present in the prior 13F-HR filing.
| Company | Ticker | Initial Portfolio Weight | History |
|---|---|---|---|
| UNITEDHEALTH GROUP INC | UNH | 6.7% | History → |
| VENTURE GLOBAL INC | VG | 4.8% | Holders → |
| AZUL S A | AZUL | 3.8% | Holders → |
| OCCIDENTAL PETE CORP | OXY | 3.0% | Holders → |
| CALIFORNIA RES CORP | CRC | 2.3% | Holders → |
Top BuysQ2 2026
The fund's top buys among existing positions in Q2 2026. Ranked by portfolio-weight impact, with the percentage of additional shares shown separately.
| Company | Ticker | Portfolio Weight Change | More Shares | History |
|---|---|---|---|---|
| NXP SEMICONDUCTORS N V | NXPI | +2.7% | +50.0% | History → |
| NIQ GLOBAL INTELLIGENCE PLC | NIQ | +-0.3% | +40.0% | History → |
| MCGRAW HILL INC | MH | +-2.8% | +17.3% | History → |
Top SellsQ2 2026
The fund's top sells among positions it retained in Q2 2026. Ranked by portfolio-weight impact. Full exits are listed separately.
| Company | Ticker | Portfolio Weight Change | Shares Sold | History |
|---|---|---|---|---|
| COGENT COMMUNICATIONS HLDGS | CCOI | -2.0% | 50.0% | Holders → |
| AMNEAL PHARMACEUTICALS INC | AMRX | -0.6% | 21.2% | History → |
| DIVERSIFIED HEALTHCARE TR | DHC | -0.2% | 15.3% | History → |
| ROIVANT SCIENCES LTD | ROIV | -1.4% | 12.5% | History → |
| VIKING THERAPEUTICS INC | VKTX | -0.3% | 3.5% | History → |
Full ExitsQ2 2026
Positions present in the prior 13F-HR filing that no longer appear in Q2 2026.
| Company | Ticker | Last-Reported Portfolio Weight |
|---|---|---|
| VEECO INSTRS INC DEL | VECO | 10.2% |
| GLOBAL BUSINESS TRAVEL GROUP | GBTG | 3.4% |
Net Portfolio Value ChangeQ2 2026
- $0.3BPrior quarter
- $0.4BCurrent quarter
- +$0.1BNet delta
- +21.0%% change
Methodology & FAQ
How BlackBarn Capital Partners LP Quarterly Changes Are Computed
All deltas are sourced from sequential SEC Form 13F-HR filings for BlackBarn Capital Partners LP: each row joins the most recent filing against the immediately preceding quarterly filing for the same fund. Share-count changes reflect reported trading activity, while portfolio weights can also move because of market price changes. Portfolio weights are normalized to exclude listed options for comparability. A complete description, including how confidential treatment filings are handled, is documented in the Methodology.
What stocks did BlackBarn Capital Partners LP buy in Q2 2026?
In Q2 2026, BlackBarn Capital Partners LP initiated 5 new positions (UNITEDHEALTH GROUP INC (UNH), VENTURE GLOBAL INC (VG), AZUL S A (AZUL), OCCIDENTAL PETE CORP (OXY), CALIFORNIA RES CORP (CRC)); bought more shares of NXP SEMICONDUCTORS N V (NXPI), NIQ GLOBAL INTELLIGENCE PLC (NIQ), MCGRAW HILL INC (MH).
What stocks did BlackBarn Capital Partners LP sell in Q2 2026?
In Q2 2026, BlackBarn Capital Partners LP fully sold 2 positions (VEECO INSTRS INC DEL (VECO), GLOBAL BUSINESS TRAVEL GROUP (GBTG)); reduced holdings in COGENT COMMUNICATIONS HLDGS (CCOI), AMNEAL PHARMACEUTICALS INC (AMRX), DIVERSIFIED HEALTHCARE TR (DHC), ROIVANT SCIENCES LTD (ROIV), VIKING THERAPEUTICS INC (VKTX).
Which positions did BlackBarn Capital Partners LP initiate in Q2 2026?
BlackBarn Capital Partners LP established 5 new positions in Q2 2026: UNITEDHEALTH GROUP INC (UNH, 6.7%), VENTURE GLOBAL INC (VG, 4.8%), AZUL S A (AZUL, 3.8%), OCCIDENTAL PETE CORP (OXY, 3.0%), CALIFORNIA RES CORP (CRC, 2.3%).
Which existing positions saw the largest allocation increases for BlackBarn Capital Partners LP in Q2 2026?
Of 3 existing positions with share-count increases in Q2 2026, the largest were: NXP SEMICONDUCTORS N V (NXPI, +2.7% weight, +50.0% shares), NIQ GLOBAL INTELLIGENCE PLC (NIQ, +-0.3% weight, +40.0% shares), MCGRAW HILL INC (MH, +-2.8% weight, +17.3% shares).
Which positions did BlackBarn Capital Partners LP fully exit in Q2 2026?
BlackBarn Capital Partners LP fully exited 2 positions in Q2 2026: VEECO INSTRS INC DEL (VECO, last-reported weight 10.2%), GLOBAL BUSINESS TRAVEL GROUP (GBTG, last-reported weight 3.4%).
Which existing positions saw the largest allocation reductions for BlackBarn Capital Partners LP in Q2 2026?
Of 5 existing positions with share-count reductions in Q2 2026, the largest were: COGENT COMMUNICATIONS HLDGS (CCOI, -2.0% weight, -50.0% shares), AMNEAL PHARMACEUTICALS INC (AMRX, -0.6% weight, -21.2% shares), DIVERSIFIED HEALTHCARE TR (DHC, -0.2% weight, -15.3% shares), ROIVANT SCIENCES LTD (ROIV, -1.4% weight, -12.5% shares), VIKING THERAPEUTICS INC (VKTX, -0.3% weight, -3.5% shares).
Do quarter-over-quarter 13F allocation changes constitute explicit trading signals?
No. Quarter-over-quarter changes reflect a combination of active trading and market price movement. A weight increase can result from price appreciation alone, without the manager adding shares. Share-count delta is the cleaner indicator of explicit trading activity. All deltas on this page are sourced from sequential SEC Form 13F-HR filings.